SER Serina Therapeutics, Inc.
Fundamentals / CIK 0001708599 / USDSerina Therapeutics, Inc. reported $130K in revenue and a net loss of $24.50M for the fiscal year ended December 31, 2025 (up 132.1% year over year), with a -20870.8% operating margin.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open SER in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2025$130K +132.1% YoY
-
Operating Income FY 2025-$27.13M -20870.8% margin
-
Net Income FY 2025-$24.50M -18843.1% net margin
-
Diluted EPS FY 2025-$0.96 Split-adjusted
-
Free Cash Flow FY 2025-$22.84M -17566.2% FCF margin
-
Cash & ST Investments Sep 30, 2026$19.40M Total debt: $197K
Annual revenue and net income
9 fiscal years (2017 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $130K | $56K | $3.15M | $34K | $144K | $361K | $1.73M | $1.40M | $1.40M |
| Cost of Revenue | -- | -- | $40K | $13K | $19K | $26K | $244K | $364K | $168K |
| Gross Profit | -- | -- | $102K | $21K | $125K | $335K | $1.48M | $1.03M | $1.24M |
| Research & Development | $13.15M | $7.48M | $2.39M | $1.02M | $1.46M | $3.71M | $5.90M | $5.83M | $5.78M |
| Total Operating Expenses | $24.15M | $17.10M | $6.28M | $7.00M | $8.16M | $10.44M | $14.04M | $12.28M | $9.65M |
| Operating Income | -$24.02M | -$17.05M | -$3.13M | -$6.97M | -$7.93M | -$10.10M | -$12.56M | -$11.24M | -$6.66M |
| EBITDA | -$23.92M | -$16.95M | -$3.04M | -- | -- | -$9.40M | -$12.17M | -$10.71M | -$5.98M |
| Interest Expense | $213K | $526K | $4.90M | $3.33M | $1.10M | -- | -- | -- | -- |
| Income Before Tax | -$19.20M | -$11.21M | $5.27M | $10.50M | $8.70M | -$11.13M | -$12.24M | -- | -- |
| Income Tax Expense | $18K | $0 | $0 | -- | -- | -$150K | $148K | -- | -- |
| Net Income | -$19.18M | -$11.14M | $5.27M | -$10.46M | -$8.68M | -$10.87M | -$12.15M | -$7.50M | -$6.58M |
| Basic EPS | -$1.91 | -$1.51 | $83.10 | -$12,026.38 | -$285.16 | -$359.55 | -$409.14 | -$260.37 | -$260.37 |
| Diluted EPS | -$1.91 | -$1.51 | $25.70 | -$12,026.38 | -$285.16 | -$359.55 | -$409.14 | -$260.37 | -$260.37 |
| Basic Shares Outstanding | 10.2M | 7.4M | 63.5K | 1 | 30.6K | 30.4K | 30.1K | 28.2K | 24.7K |
| Diluted Shares Outstanding | 10.2M | 7.4M | 208.8K | 1 | 30.6K | 30.4K | 30.1K | 28.2K | 24.7K |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $125K | $0 | -- | $130K | $0 | $130K | $0 | -$14K |
| Research & Development | $4.63M | $3.82M | $3.20M | $3.40M | $3.65M | $3.15M | $2.95M | $2.37M |
| Total Operating Expenses | $7.99M | $6.78M | $6.28M | $6.21M | $6.39M | $5.70M | $5.86M | $5.54M |
| Operating Income | -$7.86M | -$6.78M | -$6.28M | -$6.21M | -$6.39M | -$5.57M | -$5.86M | -$5.55M |
| EBITDA | -$7.84M | -$6.77M | -$6.28M | -$6.18M | -$6.38M | -$5.55M | -$5.86M | -$5.49M |
| Interest Expense | $204K | $203K | $189K | $198K | $6.0K | $9.0K | $0 | $17K |
| Income Before Tax | -- | -- | -$6.89M | -- | -- | -- | -$4.82M | -- |
| Income Tax Expense | -- | -- | $7.0K | -- | -- | -- | $0 | -- |
| Net Income | -$7.91M | -$6.36M | -$6.90M | -$3.34M | -$4.58M | -$6.45M | -$4.81M | -$2.74M |
| Basic EPS | -$0.31 | -$0.55 | -$0.58 | -- | -$0.45 | -$0.66 | -$0.49 | -- |
| Diluted EPS | -$0.31 | -$0.55 | -$0.58 | -- | -$0.45 | -$0.66 | -$0.49 | -- |
| Basic Shares Outstanding | 25.4M | 16.4M | 12.0M | -- | 10.3M | 10.0M | 9.8M | -- |
| Diluted Shares Outstanding | 25.4M | 16.4M | 12.0M | -- | 10.3M | 10.0M | 9.8M | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $3.06M | $3.67M | $7.62M | $645K | $584K | $527K | $2.35M | $6.71M | $7.38M |
| Cash & Short-Term Investments | $3.06M | $3.67M | $7.62M | $645K | $584K | $527K | $2.35M | $6.71M | $7.38M |
| Accounts Receivable, Net | -- | -- | $57K | $4.0K | $25K | $326K | $363K | $131K | $107K |
| Other Current Assets | $309K | $77K | $0 | -- | -- | -- | -- | -- | -- |
| Total Current Assets | $6.08M | $5.68M | $7.62M | $2.45M | $2.23M | $2.28M | $4.05M | $7.85M | $7.59M |
| Property, Plant & Equipment, Net | $465K | $501K | $573K | -- | -- | -- | $1.13M | $90K | $129K |
| Intangible Assets | -- | -- | $0 | $738K | $870K | $1.59M | $2.15M | $2.71M | $1.87M |
| Other Non-Current Assets | $29K | -- | -- | -- | -- | -- | -- | -- | -- |
| Total Non-Current Assets | $871K | $1.05M | $1.35M | $788K | $920K | $1.64M | $3.39M | $2.82M | $2.04M |
| Total Assets | $6.95M | $6.72M | $8.97M | $3.24M | $3.15M | $3.92M | $7.44M | $10.67M | $9.63M |
| Accounts Payable | $1.93M | $744K | $580K | $568K | $193K | $761K | $420K | $150K | $75K |
| Deferred Revenue (Current) | -- | -- | -- | -- | -- | $275K | $283K | $317K | $180K |
| Other Current Liabilities | $337K | $193K | $250K | $141K | -- | -- | -- | $625K | $154K |
| Total Current Liabilities | $3.56M | $2.37M | $1.41M | $10.08M | $8.97M | $5.36M | $3.30M | $2.44M | -- |
| Long-Term Debt | -- | -- | -- | $18.12M | $13.20M | -- | -- | -- | -- |
| Deferred Revenue (Non-Current) | -- | -- | -- | -- | -- | $64K | -- | -- | -- |
| Total Non-Current Liabilities | $3.42M | $3.85M | $3.44M | $10.48M | $6.06M | $3.96M | $1.53M | $0 | -- |
| Total Liabilities | $6.99M | $6.22M | $4.86M | $20.56M | $15.03M | $9.32M | $4.83M | $2.44M | $1.31M |
| Total Debt (incl. Leases) | $377K | $461K | $712K | $18.12M | $13.20M | -- | $428K | -- | -- |
| Common Stock | $1.0K | $1.0K | $0 | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $3.0K |
| Retained Earnings | -$63.50M | -$44.32M | -$33.18M | -$116.2M | -$105.7M | -$97.07M | -$86.21M | -$74.05M | -$66.55M |
| Accumulated Other Comp. Income | -$14K | $0 | -- | -- | -- | $143K | $69K | -$2.0K | $68K |
| Total Stockholders' Equity | -$37K | $641K | -$32.29M | -$37.78M | -$11.83M | -$5.12M | $2.22M | $7.45M | $7.28M |
| Total Equity | -$37K | $508K | -$32.29M | -$37.78M | -$11.88M | -$5.40M | $2.62M | $8.23M | $8.32M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $19.40M | $23.02M | $24.53M | $3.06M | $8.62M | $6.04M | $4.27M | $3.67M |
| Cash & Short-Term Investments | $19.40M | $23.02M | $24.53M | $3.06M | $8.62M | $6.04M | $4.27M | $3.67M |
| Other Current Assets | $107K | $0 | $333K | $309K | $170K | $177K | $150K | $77K |
| Total Current Assets | $20.93M | $25.03M | $26.47M | $6.08M | $11.50M | $7.99M | $5.75M | $5.68M |
| Property, Plant & Equipment, Net | $466K | $482K | $472K | $465K | $580K | $588K | $484K | $501K |
| Other Non-Current Assets | $82K | -- | -- | $29K | -- | -- | -- | -- |
| Total Non-Current Assets | $942K | $784K | $825K | $871K | $916K | $950K | $977K | $1.05M |
| Total Assets | $21.87M | $25.81M | $27.30M | $6.95M | $12.41M | $8.94M | $6.73M | $6.72M |
| Accounts Payable | $1.34M | $1.86M | $2.83M | $1.93M | $2.73M | $1.71M | $1.19M | $744K |
| Other Current Liabilities | $711K | $545K | $456K | $337K | $350K | $545K | $185K | $193K |
| Total Current Liabilities | $4.53M | $3.76M | $6.34M | $3.56M | $8.79M | $3.56M | $2.35M | $2.37M |
| Total Non-Current Liabilities | $3.42M | $3.32M | $3.33M | $3.42M | $2.03M | $3.73M | $2.82M | $3.85M |
| Total Liabilities | $7.95M | $7.08M | $9.67M | $6.99M | $10.82M | $7.29M | $5.17M | $6.22M |
| Total Debt (incl. Leases) | $197K | $122K | $327K | $377K | $311K | $362K | $412K | $461K |
| Common Stock | $3.0K | $3.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K |
| Retained Earnings | -$84.66M | -$76.75M | -$70.40M | -$63.50M | -$60.16M | -$55.58M | -$49.13M | -$44.32M |
| Accumulated Other Comp. Income | -$4.0K | $0 | -$8.0K | -$14K | -$4.0K | -- | -- | $0 |
| Total Stockholders' Equity | $13.92M | -- | -- | -$37K | $1.76M | $1.80M | $1.70M | $641K |
| Total Equity | $13.92M | $18.73M | $17.63M | -$37K | $1.59M | $1.65M | $1.56M | $508K |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$19.21M | -$11.21M | $5.27M | -$10.52M | -$8.69M | -$10.98M | -$12.38M | -$7.73M | -$6.64M |
| Depreciation & Amortization | $100K | $100K | $90K | -- | -- | $699K | $393K | $535K | $682K |
| Stock-Based Compensation | $3.79M | $2.60M | $25K | $760K | $999K | $909K | $1.91M | $1.28M | $114K |
| Change in Payables | $1.20M | -$1.66M | $393K | -- | -- | -- | -- | -- | -- |
| Operating Cash Flow | -$17.95M | -$17.14M | -$2.48M | -$5.94M | -$7.86M | -$7.82M | -$10.16M | -$8.00M | -$6.29M |
| Capital Expenditure | -$59K | -$22K | -$504K | -- | -- | -$20K | -$641K | -$21K | -$1.0K |
| Free Cash Flow | -$18.01M | -$17.16M | -$2.98M | -- | -- | -$7.84M | -$10.80M | -$8.02M | -$6.29M |
| Investing Cash Flow | -$59K | -$22K | -$504K | -- | $666K | -$20K | -$361K | $1.33M | $5.0K |
| Common Stock Issued | -- | -- | -- | -- | $496K | -- | -- | $5.00M | $10.00M |
| Financing Cash Flow | $17.41M | $13.21M | $10.07M | $6.00M | $7.25M | $5.96M | $6.26M | $6.00M | $13.28M |
| Net Change in Cash | -$616K | -$3.95M | $7.09M | $61K | $57K | -$1.88M | -$4.25M | -$668K | $7.12M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$7.91M | -$6.36M | -$6.90M | -$3.34M | -$4.59M | -$6.46M | -$4.82M | -$2.75M |
| Depreciation & Amortization | $19K | $18K | $0 | $24K | $16K | $16K | $0 | $56K |
| Stock-Based Compensation | $1.07M | $1.05M | $1.08M | $948K | $999K | $890K | $956K | $988K |
| Change in Payables | -$473K | -$967K | $896K | -$811K | $1.04M | $522K | $441K | -$949K |
| Operating Cash Flow | -$5.50M | -$6.68M | -$4.57M | -$6.03M | -$3.85M | -$3.75M | -$4.32M | -$4.59M |
| Capital Expenditure | -$3.0K | -$28K | -$25K | $0 | -$13K | -$46K | $0 | -$5.0K |
| Free Cash Flow | -$5.50M | -$6.71M | -$4.59M | -$6.03M | -$3.86M | -$3.80M | -$4.32M | -$4.59M |
| Investing Cash Flow | -$3.0K | -$28K | -$25K | $0 | -$13K | -$46K | $0 | -$5.0K |
| Common Stock Issued | -- | -- | -- | -- | -- | -- | $4.92M | -- |
| Financing Cash Flow | $1.88M | $5.20M | $26.06M | $481K | $6.44M | $5.57M | $4.92M | $5.03M |
| Net Change in Cash | -$3.62M | -$1.50M | $21.47M | -$5.56M | $2.58M | $1.77M | $595K | $437K |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | -- | -- | 3.2% | 61.8% | 86.8% | 92.8% | 85.9% | 73.9% | 88.0% |
| Operating Margin | -18478.5% | -30442.9% | -99.2% | -20514.7% | -5509.0% | -2797.8% | -726.8% | -805.5% | -474.6% |
| Net Profit Margin | -14755.4% | -19894.6% | 167.1% | -30770.6% | -6024.3% | -3009.7% | -703.4% | -537.4% | -468.7% |
| Return on Equity (ROE) | -- | -1738.1% | -- | -- | -- | -- | -548.0% | -100.7% | -90.4% |
| Return on Assets (ROA) | -276.0% | -165.7% | 58.8% | -322.8% | -275.0% | -276.8% | -163.3% | -70.3% | -68.3% |
| Current Ratio | 1.71x | 2.40x | 5.39x | 0.24x | 0.25x | 0.43x | 1.23x | 3.22x | -- |
| Quick Ratio | 0.86x | 1.55x | 5.43x | 0.06x | 0.07x | 0.16x | 0.82x | 2.80x | -- |
| Debt to Equity | -- | 0.72x | -- | -- | -- | -- | 0.19x | -- | -- |
| Revenue Growth (YoY) | +132.1% | -98.2% | +9173.5% | -76.4% | -60.1% | -79.1% | +23.8% | -0.6% | -- |
| Gross Profit Growth (YoY) | -- | -- | +385.7% | -83.2% | -62.7% | -77.4% | +43.8% | -16.5% | -- |
| Net Income Growth (YoY) | -- | -311.4% | -- | -- | -- | -- | -- | -- | -- |
| EPS Growth (YoY) | -- | -101.8% | -- | -- | -- | -- | -- | -- | -- |
| 5Y Revenue / Share Growth | -99.9% | -100.0% | +0.2% | +59753.6% | -- | -- | -- | -- | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -- | -- | -- | -9239.2% | -20141.4% | -17141.5% | -40362.7% | -30442.9% |
| Net Profit Margin | -- | -- | -- | -7377.7% | -16022.4% | -9685.4% | -1841.2% | -19894.6% |
| Return on Equity (ROE) | -176.0% | -- | -- | -- | -1056.0% | -698.7% | -55.2% | -1738.1% |
| Return on Assets (ROA) | -112.0% | -82.0% | -77.9% | -276.0% | -149.7% | -140.8% | -14.0% | -165.7% |
| Current Ratio | 4.62x | 6.65x | 4.18x | 1.71x | 1.31x | 2.24x | 2.45x | 2.40x |
| Quick Ratio | 4.28x | 6.12x | 3.87x | 0.86x | 0.98x | 1.70x | 1.81x | 1.55x |
| Debt to Equity | 0.01x | -- | -- | -- | 0.18x | 0.20x | 0.24x | 0.72x |
| Revenue Growth (YoY) | -- | -100.0% | -- | -- | -100.0% | +154.9% | -100.0% | -100.5% |
| Operating Income Growth (YoY) | -- | -- | -- | -- | -- | -- | -- | -2402.5% |
| Net Income Growth (YoY) | -- | -- | -- | -- | -425.2% | -223.9% | -- | -360.7% |
| EPS Growth (YoY) | -- | -- | -- | -- | -108.0% | -103.1% | -- | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -- | -- | -- | -- | -3892.6% |